Pharmacist's Guide to Managing Anemia in Chronic Kidney Disease

Program Type



1 Contact Hour(s)

Release Date

Monday, August 21, 2017

Offline Date:

Friday, August 21, 2020

ACPE Expiration Date

Friday, August 21, 2020

Target Audience




  • Overview

    To educate participants on the treatment recommendations and goals for patients with anemia and chronic kidney disease.  The session will begin with an overview of chronic kidney disease including delineation of stages, epidemiology, and complications.  Particular focus will be on anemia in CKD – its causes, symptoms, diagnosis and treatment.  The guidelines for managing anemia in CKD and available medications will be covered in detail.  The discussion of treatment options will outline dosing, administration routes, warnings and contraindications, potential adverse effects, and monitoring.  Participants will have an opportunity to review patient cases and select the appropriate treatment strategy for each. 


    Speaker:  Indu Lew, PharmD; Vice President Corporate Pharmacy-Clinical Pharmacy Services,

                     RWJBarnabas Health, West Orange, NJ


    Dr. Lew is on the speaker’s bureaus for American Regent and Amgen; presenter is also on the Advisory board of Novartis.


    Reviewer: Darren Grabe, PharmD; Associate Professor of Pharmacy Practice, Albany College of Pharmacy; Adjunct Assistant Professor, Albany Medical College; Albany Nephrology Pharmacy Group, Albany, NY.

    Dr. Grabe does not have any relevant financial relationships with any commercial interests.


    Support for this activity:

    • Educational grant funding was received from American Regent


    American Health Resources assesses conflict of interest with its instructors, reviewers and other individuals who are in a position to control the content of CE activities. All relevant conflicts of interest that are identified are resolved by American Health Resources for fair balance and scientific objectivity.

    Disclosure of Unlabeled Use

    This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA.  American Health Resources does not recommend the use of any agent outside of the labeled indications.  The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of American Health Resources.  Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.



    Slide Document:   1-CKD - Slides for Web - V5 - update 8.8 HANDOUTS.pdf

    Financial Support By

    American Regent
  • Pharmacist

    Explain the impact of anemia on quality of life and mortality risk.
    Compare and contrast therapies used in the management of anemia in patients with CKD.
    Discuss laboratory tests and monitoring parameters used to evaluate anemia.
    Identify a treatment plan for management of anemia based on patient specific factors.

  • Activity Type


    Universal Activity Number

    Pharmacist 0280-0000-17-096-H01-P

    ACPE PharmCon, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

    PharmCon, Inc. is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

    In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

  • Faculty

    Indu Lew, PharmD
    Vice President Corporate Pharmacy - Clinical Pharmacy Services RWJ Barnabas Health


843 488 5550 Office

843 488 5554 Fax Email Web

341 Wellness Drive, Myrtle Beach, SC 29579 Address

©2015 PharmCon, lnc. All Rights Reserved | Terms & Conditions | Privacy PolicyAmerican Health Resources, LLC a subsidiary of PharmCon, Inc.
Developed By: ITB, Inc.